Christopher Liong, Chairman   Chris is the Co-Founder, Chief Investment Officer and Portfolio Manager at Bergamot Asset Management, LLC. Prior to Bergamot, Chris was a Managing Partner and a Portfolio Manager at Suffolk Capital Management. Chris joined Suffolk Capital Management in May 1996, as a Research Analyst covering the Technology and Telecommunications sectors. He was named as the first Director of Research in 1999 and became the Portfolio Manager for the Large Cap Growth Strategy in 2001. In 2013, Chris became the Portfolio Manager for the Small Cap Growth strategy. Chris received his Bachelor of Science Degree in Material Science and Engineering from Cornell University.

Christopher Liong, Chairman

Chris is the Co-Founder, Chief Investment Officer and Portfolio Manager at Bergamot Asset Management, LLC. Prior to Bergamot, Chris was a Managing Partner and a Portfolio Manager at Suffolk Capital Management. Chris joined Suffolk Capital Management in May 1996, as a Research Analyst covering the Technology and Telecommunications sectors. He was named as the first Director of Research in 1999 and became the Portfolio Manager for the Large Cap Growth Strategy in 2001. In 2013, Chris became the Portfolio Manager for the Small Cap Growth strategy. Chris received his Bachelor of Science Degree in Material Science and Engineering from Cornell University.

Jon Liong, CEO & Managing Director   Jon has been creating life sciences / healthcare events for over 19 years with experience both in US and China-focused on conferences. He helped launch the China industry's first R&D conference (Impact China 2005), first clinical development conference (ChinaTrials 2008), first medical affairs conference (China Medical Affairs Summit 2012), first investor-focused event (China Healthcare Investment Conference CHIC 2010) and first US-China simultaneous clinical development event (ChinaTrials+US 2019).

Jon Liong, CEO & Managing Director

Jon has been creating life sciences / healthcare events for over 19 years with experience both in US and China-focused on conferences. He helped launch the China industry's first R&D conference (Impact China 2005), first clinical development conference (ChinaTrials 2008), first medical affairs conference (China Medical Affairs Summit 2012), first investor-focused event (China Healthcare Investment Conference CHIC 2010) and first US-China simultaneous clinical development event (ChinaTrials+US 2019).

Eric Lu, Vice President, Operations

Eric Lu, Vice President, Operations

 
Hidy Fu, Director

Hidy Fu, Director

Louisa Chen, Director

Louisa Chen, Director

Johanna Leeuwen, Associate Director

Johanna Leeuwen, Associate Director